Agenda: Spotlight on HIV/AIDS
Spotlight on HIV/AIDS On April 29, 2010, the CIRM Governing Board heard from several speakers about the CIRM HIV/AIDS Disease Team Awards. Click the speaker's name or photos below to…
Spotlight on HIV/AIDS On April 29, 2010, the CIRM Governing Board heard from several speakers about the CIRM HIV/AIDS Disease Team Awards. Click the speaker's name or photos below to…
Spotlight on Huntington's Disease On March 11, 2010, the CIRM Governing Board heard from several speakers about Huntington's disease, an inherited neurodegenerative disorder. Click the seminar title or photos below…
Spotlight on Epidermolysis Bullosa On February 4, 2010, the CIRM Governing Board heard from several speakers about epidermolysis bullosa (EB), a devastating childhood skin disease. CIRM funds a multidisciplinary Disease…
Spotlight on Cancer Stem Cells On December 10, 2009, the CIRM Governing Board heard from Dr. Michael Clarke about cancer stems cells. Dr. Clarke is associate director of the Stanford…
Spotlight on Basic Research On August 20, 2009, the CIRM Governing Board heard from two speakers about the key role of basic research in developing therapies for patients. Irv Weissman…
Spotlight on Leukemia On June 18, 2009, the CIRM Governing Board heard from Catriona Jamieson about the promise of stem cell research in treating leukemia. Dr. Jamieson described how her…
Spotlight on Macular Degeneration On April 29, 2009, the CIRM Governing Board heard from four speakers about the promise of stem cell research in treating macular degeneration. Carmen Puliafito presented…
Spotlight on Arthritis On January 30, 2009, the CIRM Governing Board heard from three speakers about the promise of stem cell research in treating arthritis. They learned about the different…
Spotlight on Alzheimer's Disease On December 10, 2008, the CIRM Governing Board heard from three speakers about the promise of stem cell research in treating Alzheimer's disease. They learned about living…
Spotlight on Diabetes On September 25, 2008, the CIRM Governing Board heard from three speakers about the promise of stem cell research in treating Type 1 diabetes, formerly known as…